• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

proprietary戊酸二氟可龙外用制剂的比较变白活性

Comparative blanching activities of proprietary diflucortolone valerate topical preparations.

作者信息

Coleman G L, Kanfer I, Haigh J M

出版信息

Dermatologica. 1978;156(4):224-30. doi: 10.1159/000250920.

DOI:10.1159/000250920
PMID:342295
Abstract

The blanching activities and hence bioavailabilities of the cream, ointment and fatty ointment preparations of Nerisone and Temetex (diflucortolone valerate 0.1%) were evaluated using an occluded and unoccluded blanching assay. These products were compared to Synalar ointment and cream (fluocinolone acetonide 0.025%), established topical corticosteroid preparations. Statistical analysis showed no significant differences between similar formulations of diflucortolone valerate. Significant differences were noted between diflucortolone valerate and fluocinolone acetonide preparations.

摘要

采用封包和非封包变白试验,对Nerisone和Temetex(戊酸二氟可龙0.1%)乳膏、软膏和脂肪性软膏制剂的变白活性及生物利用度进行了评估。将这些产品与已有的外用皮质类固醇制剂Synalar软膏和乳膏(醋酸氟轻松0.025%)进行比较。统计分析表明,戊酸二氟可龙类似制剂之间无显著差异。戊酸二氟可龙制剂和醋酸氟轻松制剂之间存在显著差异。

相似文献

1
Comparative blanching activities of proprietary diflucortolone valerate topical preparations. proprietary戊酸二氟可龙外用制剂的比较变白活性
Dermatologica. 1978;156(4):224-30. doi: 10.1159/000250920.
2
Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
Dermatologica. 1976;153(4):236-42. doi: 10.1159/000251062.
3
Comparative blanching activities of locally manufactured proprietary fluocinolone acetonide topical preparations.本地生产的专利氟轻松丙酮 topical 制剂的比较脱色活性。 (注:这里“topical”结合语境可能更准确的意思是“局部用的”,整句可优化为“本地生产的专利氟轻松丙酮局部用制剂的比较脱色活性” )
S Afr Med J. 1979 Sep 8;56(11):447-9.
4
[Topical treatment of dermatoses with difluocortolone valerate fatty ointment].
Z Hautkr. 1976;51 Suppl 1:27-9.
5
[Double-blind comparative study between difluocortolone-valerianate and fluocinolone-acetonide ointments].戊酸二氟可的索与醋酸氟轻松软膏的双盲对照研究
Prensa Med Mex. 1977 Mar-Apr;42(3-4):183-6.
6
[Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part I: Comparative study of diflucortolone valerate with fluocortolone, -capronate, -pivalate in a double-blind contralateral design with topical application (author's transl)].新型皮质类固醇戊酸二氟可龙乳膏、软膏和脂肪性软膏的多中心临床试验。第一部分:戊酸二氟可龙与氟可龙、己酸酯、新戊酸酯在双侧双盲局部应用设计中的对比研究(作者译)
Arzneimittelforschung. 1976;26(7b):1499-504.
7
[Results of a multi-center, international clinical trial of difluocortolone valerate (Nerisona)].
Z Hautkr. 1976;51 Suppl 1:1-16.
8
A multicentric clinical trial with 0.1% diflucortolone valerate in Thailand.在泰国进行的一项使用0.1%戊酸地氟米松的多中心临床试验。
J Med Assoc Thai. 1977 Aug;60(8):353-61.
9
[Efficacy of diflucortolone valerate in the vasoconstriction tests].戊酸二氟可龙在血管收缩试验中的疗效
Arzneimittelforschung. 1976;26(7b):1495-8.
10
[Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part II: Comparative study with several commercial preparations (author's transl)].新型皮质类固醇戊酸二氟可龙乳膏、软膏和脂肪性软膏的多中心临床试验。第二部分:与几种市售制剂的对比研究(作者译)
Arzneimittelforschung. 1976;26(7b):1504-9.

引用本文的文献

1
Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations.采用卵磷脂/壳聚糖纳米粒增强二氟可龙戊酸酯的透皮传递:体外与体内评价。
Int J Nanomedicine. 2013;8:461-75. doi: 10.2147/IJN.S40519. Epub 2013 Jan 30.
2
Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.对美国食品药品监督管理局(FDA)提议的用于局部用皮质类固醇生物等效性测试的剂量反应试验方法的评估。
Pharm Res. 1998 Jan;15(1):4-7. doi: 10.1023/a:1011980115866.